Janus Henderson Group
ECYT

Janus Henderson Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Janus Henderson Group’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,758,435
Closed -$31.2M – 1463
2018
Q3 		$31.2M Buy
+1,758,435
New +$30.2M 0.02% 700

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Janus Henderson Group's ECYT Position: Q4 2018 in Review

Janus Henderson Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 1,758,435 shares — an estimated $31.2M sold.

Janus Henderson Group first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $31.2M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Janus Henderson Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Janus Henderson Group sold 1,758,435 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $31.2M.
  • Janus Henderson Group first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Janus Henderson Group's Endocyte, Inc. Common Stock position peaked at $31.2M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Janus Henderson Group's 13F filing for Q4 2018, filed 6 Feb 2019.